Cadila Healthcare gets EIR for Baddi plant from USFDA Kumar Jeetendra | May 29, 2020 An Establishment Inspection Report (EIR) from U.S. Food and Drug Administration (USFDA) has been gotten by Cadila Healthcare’s assembling office at Baddi, India, arranging the office as ‘No Action Indicated (NAI)’. An examination by USFDA had been directed at the office from March 02 to March 09, 2020, which finished with nil perceptions. USFDA had …
Everything You Need to Know About Pharmaceutical Lab Innovation Kumar Jeetendra | December 6, 2022 India’s pharmaceuticals industry is a major player in the global pharmaceuticals market. India is ranked third in the world for production volume and 14th for value. India is the world’s largest supplier of generic medicines, with a share of 20% in global supply. It is also the top vaccine manufacturer worldwide. India is also home …
Pharmaceutical Roots: Justicia Adhatoda – from ancient medicine to novel drug candidate Kumar Jeetendra | February 6, 2023 Pharmaceutical Roots is a content series from LGC Mikromol investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Introduction It’s been used for thousands of years in Indian and European medicine and also formed the basis of modern drugs for coughs, colds …
Here is a list of the leading 10 pharmaceutical companies in India Kumar Jeetendra | March 2, 2023 India is well-known for establishing a strong foothold in the global pharmaceutical business. It has expanded considerably in recent years. There are over 60,000 generic brands in 60 therapeutic areas. India’s Pharma companies generate about 500 different active pharmaceutical ingredients (APIs). Over 50% of Africa’s need for generic drugs is met by India, as is …
